1. Home
  2. WK vs CRSP Comparison

WK vs CRSP Comparison

Compare WK & CRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WK
  • CRSP
  • Stock Information
  • Founded
  • WK 2008
  • CRSP 2013
  • Country
  • WK United States
  • CRSP Switzerland
  • Employees
  • WK N/A
  • CRSP N/A
  • Industry
  • WK Computer Software: Prepackaged Software
  • CRSP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WK Technology
  • CRSP Health Care
  • Exchange
  • WK Nasdaq
  • CRSP Nasdaq
  • Market Cap
  • WK 4.0B
  • CRSP 3.3B
  • IPO Year
  • WK 2014
  • CRSP 2016
  • Fundamental
  • Price
  • WK $67.27
  • CRSP $36.29
  • Analyst Decision
  • WK Strong Buy
  • CRSP Buy
  • Analyst Count
  • WK 9
  • CRSP 16
  • Target Price
  • WK $107.00
  • CRSP $73.07
  • AVG Volume (30 Days)
  • WK 649.2K
  • CRSP 2.1M
  • Earning Date
  • WK 05-01-2025
  • CRSP 05-06-2025
  • Dividend Yield
  • WK N/A
  • CRSP N/A
  • EPS Growth
  • WK N/A
  • CRSP N/A
  • EPS
  • WK N/A
  • CRSP N/A
  • Revenue
  • WK $769,293,000.00
  • CRSP $37,675,000.00
  • Revenue This Year
  • WK $20.81
  • CRSP $26.79
  • Revenue Next Year
  • WK $16.31
  • CRSP $297.32
  • P/E Ratio
  • WK N/A
  • CRSP N/A
  • Revenue Growth
  • WK 17.36
  • CRSP N/A
  • 52 Week Low
  • WK $60.50
  • CRSP $30.04
  • 52 Week High
  • WK $116.83
  • CRSP $67.88
  • Technical
  • Relative Strength Index (RSI)
  • WK 41.47
  • CRSP 46.12
  • Support Level
  • WK $66.19
  • CRSP $35.38
  • Resistance Level
  • WK $68.52
  • CRSP $38.13
  • Average True Range (ATR)
  • WK 1.58
  • CRSP 1.73
  • MACD
  • WK -0.12
  • CRSP -0.03
  • Stochastic Oscillator
  • WK 18.59
  • CRSP 26.30

About WK Workiva Inc.

Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

Share on Social Networks: